{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T13:46:37Z","timestamp":1774791997427,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NIAID","award":["AI105170 (S.M.K.)"],"award-info":[{"award-number":["AI105170 (S.M.K.)"]}]},{"name":"NIH\/NIAID","award":["AI093772 (S.M.K.)"],"award-info":[{"award-number":["AI093772 (S.M.K.)"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.virol.2014.12.004","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T20:45:53Z","timestamp":1419885953000},"page":"217-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease"],"prefix":"10.1016","volume":"476","author":[{"given":"Yu-Na","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye","family":"Suk Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Chul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Tae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Kyoung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Man","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong","family":"Seok Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard K.","family":"Plemper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Moo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2014.12.004_bib1","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1128\/jvi.62.11.4232-4238.1988","article-title":"Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies","volume":"62","author":"Anderson","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.004_bib2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2014.01.022","article-title":"Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB\/c mice","volume":"104","author":"Bian","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virol.2014.12.004_bib3","doi-asserted-by":"crossref","first-page":"10955","DOI":"10.1128\/JVI.01164-13","article-title":"A respiratory syncytial virus (RSV) anti-G protein F(ab\u2032)2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB\/c mice","volume":"87","author":"Boyoglu-Barnum","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.004_bib4","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.4049\/jimmunol.180.4.2376","article-title":"IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease","volume":"180","author":"Castilow","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2014.12.004_bib5","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1128\/JVI.01949-07","article-title":"Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus","volume":"82","author":"Castilow","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.004_bib6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2217\/17460794.3.5.445","article-title":"Overcoming T cell-mediated immunopathology to achieve safe RSV vaccination","volume":"3","author":"Castilow","year":"2008","journal-title":"Future Virol."},{"key":"10.1016\/j.virol.2014.12.004_bib7","doi-asserted-by":"crossref","first-page":"232","DOI":"10.5483\/BMBRep.2011.44.4.232","article-title":"Current progress on development of respiratory syncytial virus vaccine","volume":"44","author":"Chang","year":"2011","journal-title":"BMB Rep."},{"key":"10.1016\/j.virol.2014.12.004_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0300-9475.2004.01382.x","article-title":"Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines","volume":"59","author":"Cox","year":"2004","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.virol.2014.12.004_bib10","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.vaccine.2003.10.008","article-title":"Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge","volume":"22","author":"De Waal","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2014.12.004_bib11","first-page":"379","article-title":"Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system","volume":"7","author":"DuBridge","year":"1987","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.virol.2014.12.004_bib12","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2014.12.004_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-065X.2010.00972.x","article-title":"Biological challenges and technological opportunities for respiratory syncytial virus vaccine development","volume":"239","author":"Graham","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.virol.2014.12.004_bib15","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1016\/S0264-410X(01)00228-6","article-title":"CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV)","volume":"19","author":"Hancock","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2014.12.004_bib16","doi-asserted-by":"crossref","first-page":"7783","DOI":"10.1128\/jvi.70.11.7783-7791.1996","article-title":"Generation of atypical pulmonary inflammatory responses in BALB\/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus","volume":"70","author":"Hancock","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.004_bib17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/600108","article-title":"Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB\/c mice","volume":"200","author":"Haynes","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2014.12.004_bib18","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1073\/pnas.100133697","article-title":"A DNA transfection system for generation of influenza A virus from eight plasmids","volume":"97","author":"Hoffmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2014.12.004_bib20","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1128\/JVI.72.4.2871-2880.1998","article-title":"Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge","volume":"72","author":"Johnson","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.004_bib21","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1128\/JVI.78.11.6024-6032.2004","article-title":"Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV","volume":"78","author":"Johnson","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.004_bib22","doi-asserted-by":"crossref","first-page":"9624","DOI":"10.1128\/JVI.78.18.9624-9632.2004","article-title":"Intranasal immunization with inactivated influenza virus enhances immune responses to coadministered simian-human immunodeficiency virus-like particle antigens","volume":"78","author":"Kang","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.004_bib23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","article-title":"An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine","volume":"89","author":"Kapikian","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.virol.2014.12.004_bib24","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.virol.2014.12.004_bib25","doi-asserted-by":"crossref","first-page":"e32226","DOI":"10.1371\/journal.pone.0032226","article-title":"Dual role of respiratory syncytial virus glycoprotein fragment as a mucosal immunogen and chemotactic adjuvant","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2014.12.004_bib26","doi-asserted-by":"crossref","first-page":"10672","DOI":"10.1128\/JVI.79.16.10672-10677.2005","article-title":"Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment","volume":"79","author":"Kittel","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.004_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virusres.2011.09.022","article-title":"Immune responses to influenza virus infection","volume":"162","author":"Kreijtz","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2014.12.004_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2014.01.008","article-title":"Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease","volume":"104","author":"Kwon","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virol.2014.12.004_bib29","doi-asserted-by":"crossref","DOI":"10.1089\/jir.2013.0093","article-title":"Ginseng diminishes lung disease in mice immunized with formalin-inactivated respiratory syncytial virus after challenge by modulating host immune responses","author":"Lee","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.virol.2014.12.004_bib30","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1128\/jvi.67.11.6659-6666.1993","article-title":"Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1","volume":"67","author":"Li","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.004_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/jvi.66.1.399-404.1992","article-title":"Influenza A virus transfectants with chimeric hemagglutinins containing epitopes from different subtypes","volume":"66","author":"Li","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.004_bib32","doi-asserted-by":"crossref","first-page":"10003","DOI":"10.1128\/JVI.79.15.10003-10012.2005","article-title":"Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity","volume":"79","author":"Li","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.004_bib33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/0192623308329342","article-title":"Comparison of histochemical methods for murine eosinophil detection in an RSV vaccine-enhanced inflammation model","volume":"37","author":"Meyerholz","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.virol.2014.12.004_bib34","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/pch\/18.8.e51","article-title":"Influenza vaccine recommendations for children and youth for the 2013\/2014 season","volume":"18","author":"Moore","year":"2013","journal-title":"Paediatr. Child Health"},{"key":"10.1016\/j.virol.2014.12.004_bib35","doi-asserted-by":"crossref","first-page":"8322","DOI":"10.1128\/JVI.77.15.8322-8328.2003","article-title":"Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice","volume":"77","author":"Mozdzanowska","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.004_bib36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0264-410X(90)90253-I","article-title":"Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization","volume":"8","author":"Murphy","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2014.12.004_bib37","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2014.12.004_bib38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0042-6822(91)90588-3","article-title":"Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses","volume":"182","author":"Nobusawa","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.virol.2014.12.004_bib39","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1128\/JVI.73.7.5637-5645.1999","article-title":"Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein","volume":"73","author":"Plotnicky-Gilquin","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.004_bib40","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.20020781","article-title":"A role for immune complexes in enhanced respiratory syncytial virus disease","volume":"196","author":"Polack","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2014.12.004_bib41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0264-410X(03)00570-X","article-title":"The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B","volume":"22","author":"Power","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2014.12.004_bib42","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1099\/0022-1317-82-12-2881","article-title":"Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine","volume":"82","author":"Prince","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2014.12.004_bib43","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1128\/JVI.01615-07","article-title":"Induction of heterosubtypic immunity to influenza virus by intranasal immunization","volume":"82","author":"Quan","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.004_bib44","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/infdis\/jir474","article-title":"Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice","volume":"204","author":"Quan","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2014.12.004_bib45","doi-asserted-by":"crossref","first-page":"9632","DOI":"10.1128\/JVI.00451-10","article-title":"Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in respiratory syncytial virus (RSV)-challenged naive and formalin-inactivated RSV-immunized BALB\/c mice","volume":"84","author":"Radu","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.004_bib46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/11207080-000000000-00000","article-title":"Live attenuated influenza vaccine (Fluenz): a guide to its use in the prevention of seasonal influenza in children in the EU","volume":"14","author":"Scott","year":"2012","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.virol.2014.12.004_bib47","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1086\/314778","article-title":"Protective efficacy against respiratory syncytial virus following murine neonatal immunization with BBG2Na vaccine: influence of adjuvants and maternal antibodies","volume":"179","author":"Siegrist","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2014.12.004_bib48","doi-asserted-by":"crossref","first-page":"e14538","DOI":"10.1371\/journal.pone.0014538","article-title":"Influenza virus-like particles containing M2 induce broadly cross protective immunity","volume":"6","author":"Song","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2014.12.004_bib49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jim.2007.07.011","article-title":"Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometry","volume":"327","author":"Stevens","year":"2007","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.virol.2014.12.004_bib50","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1084\/jem.188.10.1967","article-title":"Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus","volume":"188","author":"Tebbey","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2014.12.004_bib51","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0042-6822(91)90546-N","article-title":"Protection of BALB\/c mice from respiratory syncytial virus infection by immunization with a synthetic peptide derived from the G glycoprotein","volume":"185","author":"Trudel","year":"1991","journal-title":"Virology"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682214005406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682214005406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:31:08Z","timestamp":1758587468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682214005406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":48,"alternative-id":["S0042682214005406"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2014.12.004","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2014.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}